MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617062650 A) filed by Systimmune, Inc. on May 18, 2026, for Methods And Compositions For Treating Tumors Using Antibody Camptothecin Drug Conjugates.
Inventors include Zhu, Yi; Zhu, Hai; and Xiao, Sa.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: The application provides methods of treating a tumor or cancer in a subject using antibody-toxin conjugates having the structure shown in General Formula (I), wherein Ab is conjugated to a camptothecin derivative through a linker. Ab refers to a bispecific antibody that simultaneously targets two different epitopes or targets. In one embodiment, A...